Vanderson Rocha

Active 1997–2026

182
Papers
24,363
Citations
88
h-index
167
i10-index

Citations

Citations per year for Vanderson Rocha1983: 1 citations1991: 1 citations1993: 1 citations1998: 2 citations1999: 3 citations2000: 13 citations2001: 39 citations2002: 48 citations2003: 67 citations2004: 64 citations2005: 92 citations2006: 102 citations2007: 124 citations2008: 106 citations2009: 174 citations2010: 151 citations2011: 171 citations2012: 162 citations2013: 169 citations2014: 173 citations2015: 221 citations2016: 146 citations2017: 124 citations2018: 101 citations2019: 588 citations2020: 594 citations2021: 672 citations2022: 374 citations2023: 236 citations2024: 449 citations2025: 163 citations2026: 4 citations1984–1990: no citations, so these years are not shown1992: no citations, so this year is not shown1994–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,692 citing papers, 21.8% of this breakdownItaly: 574 citing papers, 7.4% of this breakdownFrance: 567 citing papers, 7.3% of this breakdownUnited Kingdom: 540 citing papers, 7% of this breakdownGermany: 526 citing papers, 6.8% of this breakdownSpain: 344 citing papers, 4.4% of this breakdownChina: 321 citing papers, 4.1% of this breakdownNetherlands: 282 citing papers, 3.6% of this breakdownBrazil: 229 citing papers, 3% of this breakdownIsrael: 228 citing papers, 2.9% of this breakdownCanada: 212 citing papers, 2.7% of this breakdownSwitzerland: 191 citing papers, 2.5% of this breakdown
0%21.8%Other 26.5%

Fields

  • Medicine84%
  • Biochemistry, Genetics and Molecular Biology6.5%
  • Immunology and Microbiology6.2%
  • Mathematics1.3%
  • Computer Science0.2%
  • Social Sciences0.2%
  • Other1.6%

Topics

  • Hematopoietic Stem Cell Transplantation16.4%
  • Acute Myeloid Leukemia Research6.9%
  • Acute Lymphoblastic Leukemia research4.8%
  • Immune Cell Function and Interaction4.6%
  • Mesenchymal stem cell research3.8%
  • T-cell and B-cell Immunology3.3%
  • Other60.2%

Coauthors

All papers

Open in search
  1. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hanadi Rafii El-Ayoubi, Chantal Kenzey, Peter Bader, Franco Locatelli, Annalisa Ruggeri, Mary Eapen - Blood 2016 cited by 476

  2. Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA 2024 cited by 114

  3. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2015 cited by 654

  4. Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2007 cited by 516

  5. Systematic Review of Available CAR-T Cell Trials around the World

    Authors: , , , , , , , , , , , , - Cancers 2022 cited by 75

  6. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2014 cited by 382

  7. Haematopoietic stem cell transplants: principles and indications

    Authors: , , - British Journal of Hospital Medicine 2018 cited by 143

  8. Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 327

  9. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2010 cited by 586

  10. Oxaliplatin-related thrombocytopenia

    Authors: , , , , - Annals of Oncology 2012 cited by 121

  11. Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation

    Authors: , , , , , , , , , , , , , , , , , , , , - Blood 2011 cited by 311

  12. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation

    Authors: , , , , , , , , , , , , , , , , , , - Blood 2012 cited by 173

  13. Steroid-refractory chronic graft-versus-host disease: treatment options and patient management

    Authors: , , , , - Bone Marrow Transplantation 2021 cited by 80

  14. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael P. Busch, Márcia C. Castro, Christopher Dye, Vítor H. Nascimento, Nuno R. Faria, Éster Cerdeira Sabino - Science 2021 cited by 546

  15. Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Blood 2020 cited by 109

  16. Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Françoise Bernaudin, Josu de la Fuente, Selim Corbacioglu, Éliane Gluckman - Haematologica 2019 cited by 80

  17. Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clarice Tanaka, Heraldo Possolo de Souza, Júlio Flávio Meirelles Marchini, Carlos Roberto Ribeiro de Carvalho, Juliana Carvalho Ferreira, Maura Salaroli de Oliveira, Thaís Guimarães, Carolina dos Santos Lázari, Alberto José da Silva Duarte, Ester Sabino, Marcello Mihailenko Chaves Magri, Tarcisio E. P. Barros-Filho, Maria Cristina Peres Braido Francisco - Scientific Reports 2023 cited by 37

  18. Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Régis Peffault de Latour - Bone Marrow Transplantation 2019 cited by 77

  19. Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide: A Systematic Review and Meta-Analysis Comparing Myeloablative with Reduced-Intensity Conditioning Regimens and Bone Marrow with Peripheral Blood Stem Cell Grafts

    Authors: , , , , - Transplantation and Cellular Therapy 2021 cited by 39

  20. First report of PhALLCON: A phase 3 study comparing ponatinib (pon) vs imatinib (im) in newly diagnosed patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 18

  21. Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil

    Authors: , , , , , , , , , , , , , , , , , , , - BMJ Open 2021 cited by 49

  22. The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2020 cited by 37

  23. Commensal oral microbiota impacts ulcerative oral mucositis clinical course in allogeneic stem cell transplant recipients

    Authors: , , , , , , , , , , , , - Scientific Reports 2022 cited by 25

  24. Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José L. Díez‐Martín, Elizabeth R. Duke, Joshua T. Schiffer, Annemarie M. J. Wensing, Javier Martínez‐Picado, Antonio Muscatello, Alexandra Calmy, Anaïs Chapel, Anne‐Claire Mamez, Caroline Passaes, Clarissa Brisseau, Eduardo Olivarria, Elena Knops, Eva Heger, Fatima Bikhezar, Federico Perdomo-Celis, Guido Kobbe, Ian H Gabriel, Jan van Lunzen, Judith Dalmau, Luz Martín‐Carbonero, María C. Puertas, Mari Carmen Garcia-Guerrero, Marie‐Angélique De Scheerder, Mathieu Angin, Nadine Lübke, Pascual Balsalobre, Raquel de Paz, Rolf Kaiser, Tessa Kerre, Thomas Harrer, Tom Luedde, Vanderson Rocha - The Lancet HIV 2024 cited by 23